Chemoinformaics analysis of 15-PENTADECANOLIDE
| Molecular Weight | 240.387 | nRot | 0 |
| Heavy Atom Molecular Weight | 212.163 | nRig | 17 |
| Exact Molecular Weight | 240.209 | nRing | 1 |
| Solubility: LogS | -6.15 | nHRing | 1 |
| Solubility: LogP | 6.039 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 45.3242 |
| nHD | 0 | BPOL | 30.6938 |
| QED | 0.578 |
| Synth | 2.351 |
| Natural Product Likeliness | 0.477 |
| NR-PPAR-gamma | 0.179 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.058 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.847 |
| MDCK | 0.0000255 |
| BBB | 0.338 |
| PPB | 0.967198 |
| VDSS | 1.234 |
| FU | 0.0203553 |
| CYP1A2-inh | 0.876 |
| CYP1A2-sub | 0.188 |
| CYP2c19-inh | 0.588 |
| CYP2c19-sub | 0.06 |
| CYP2c9-inh | 0.299 |
| CYP2c9-sub | 0.905 |
| CYP2d6-inh | 0.068 |
| CYP2d6-sub | 0.084 |
| CYP3a4-inh | 0.336 |
| CYP3a4-sub | 0.075 |
| CL | 5.987 |
| T12 | 0.383 |
| hERG | 0.255 |
| Ames | 0.01 |
| ROA | 0.038 |
| SkinSen | 0.958 |
| Carcinogencity | 0.156 |
| EI | 0.98 |
| Respiratory | 0.84 |
| NR-Aromatase | 0.095 |
| Antiviral | Yes |
| Prediction | 0.79012 |